Older Age and Low Body Mass Index as Predictors of Sarcopenia in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

Authors

  • Farizky Universitas Sumatera Utara
  • Andika Pradana Universitas Sumatera Utara
  • Amira Permatasari Universitas Sumatera Utara
  • Rina Amelia Universitas Sumatera Utara

DOI:

https://doi.org/10.58344/ihj.v5i3.920

Keywords:

sarcopenia, muscle mass, muscle strength

Abstract

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder frequently accompanied by systemic complications, including sarcopenia, which may reduce physical capacity and worsen clinical outcomes. This study aimed to determine the prevalence of sarcopenia and identify its associated predictors among patients with stable COPD. A cross-sectional study was conducted among 67 patients with stable COPD who attended the Pulmonology Outpatient Clinic at Universitas Sumatera Utara Hospital. Muscle mass was assessed using bioelectrical impedance analysis and expressed as the skeletal muscle index, while muscle strength was measured using a handgrip strength test. Descriptive, bivariate, and receiver operating characteristic (ROC) analyses were performed. The results showed that 55.2% of participants had reduced muscle strength, 38.8% had low muscle mass, and 29.9% met the diagnostic criteria for sarcopenia. Older age and lower body mass index (BMI) were significantly associated with sarcopenia. An age threshold of >66 years predicted sarcopenia with 75.0% sensitivity and 66.0% specificity, whereas a BMI threshold of <23 kg/m² demonstrated 76.6% sensitivity and 85.0% specificity. In conclusion, sarcopenia was prevalent even among clinically stable COPD patients. Routine assessment of age, BMI, muscle mass, and handgrip strength may support early detection and facilitate timely nutritional and rehabilitative interventions to prevent functional decline and improve patient outcomes.

References

Benz, E., Trajanoska, K., Lahousse, L., et al. (2019). Sarcopenia in COPD: A systematic review and meta-analysis. European Respiratory Review, 28(154).

Benz, E., Wijnant, S. R. A., Trajanoska, K., et al. (2022). Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: A population-based study. ERJ Open Research, 8(1).

Bosello, O., & Vanzo, A. (2021). Obesity paradox and aging. Eating and Weight Disorders—Studies on Anorexia, Bulimia and Obesity, 26(1), 27–35.

de Araújo, B. E., Teixeira, P. P., Valduga, K., et al. (2021). Prevalence, associated factors, and prognostic value of sarcopenia in patients with acute exacerbated chronic obstructive pulmonary disease: A cohort study. Clinical Nutrition ESPEN, 42, 188–194.

De Lorenzo, A., Pellegrini, M., Gualtieri, P., et al. (2022). The risk of sarcopenia among adults with normal-weight obesity in a nutritional management setting. Nutrients, 14(24), 5295.

Escriche-Escuder, A., Fuentes-Abolafio, I. J., Roldán-Jiménez, C., et al. (2021). Effects of exercise on muscle mass, strength, and physical performance in older adults with sarcopenia: A systematic review and meta-analysis according to the EWGSOP criteria. Experimental Gerontology, 151, 111420.

Ferrari, R., Caram, L. M. O., Faganello, M. M., et al. (2015). Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. International Journal of Chronic Obstructive Pulmonary Disease, 1553–1558.

He, J., Li, H., Yao, J., et al. (2023). Prevalence of sarcopenia in patients with COPD through different musculature measurements: An updated meta-analysis and meta-regression. Frontiers in Nutrition, 10, 1137371.

Hurst, J. R., & Siddharthan, T. (2020). Global burden of COPD: Prevalence, patterns, and trends. In Handbook of global health (pp. 1–20).

Jones, R. L., Noble, P. B., Elliot, J. G., et al. (2016). Airway remodelling in COPD: It’s not asthma! Respirology, 21(8), 1347–1356.

Khairani, F., Kholis, F. N., & Ngestiningsih, D. (2013). Hubungan antara skor COPD Assessment Test (CAT) dengan rasio FEV1/FVC pada pasien Penyakit Paru Obstruktif Kronik (PPOK) klinis: Studi kasus pada pasien di RSUP Dr. Kariadi Semarang. Diponegoro University.

Lippi, L., Folli, A., Curci, C., et al. (2022). Osteosarcopenia in patients with chronic obstructive pulmonary diseases: Which pathophysiologic implications for rehabilitation? International Journal of Environmental Research and Public Health, 19(21), 14314.

Martínez-Luna, N., Orea-Tejeda, A., González-Islas, D., et al. (2022). Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease. BMC Pulmonary Medicine, 22(1), 106.

Mollica, M., Aronne, L., Paoli, G., et al. (2021). Elderly with COPD: Comorbidities and systemic consequences. Journal of Gerontology and Geriatrics, 69, 32–44.

Moreira, G. L., Manzano, B. M., Gazzotti, M. R., et al. (2014). PLATINO, a nine-year follow-up study of COPD in the city of São Paulo, Brazil: The problem of underdiagnosis. Jornal Brasileiro de Pneumologia, 40, 30–37.

Perrot, L., Greil, A., Boirie, Y., et al. (2020). Prevalence of sarcopenia and malnutrition during acute exacerbation of COPD and after 6 months recovery. European Journal of Clinical Nutrition, 74(11), 1556–1564.

Petermann-Rocha, F., Chen, M., Gray, S. R., et al. (2020). New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes? Age and Ageing, 49(2), 300–304.

Polosukhin, V. V., Gutor, S. S., Du, R.-H., et al. (2021). Small airway determinants of airflow limitation in chronic obstructive pulmonary disease. Thorax, 76(11), 1079–1088.

Rao, C. M., Singh, P., Maikap, D., et al. (2021). Musculoskeletal disorders in chronic obstructive airway diseases: A neglected clinical entity. Mediterranean Journal of Rheumatology, 32(3), 118–123.

Ridwan, E. S., Wiratama, B. S., Lin, M.-Y., et al. (2021). Peak expiratory flow rate and sarcopenia risk in older Indonesian people: A nationwide survey. PLOS ONE, 16(2), e0246179.

Sepúlveda-Loyola, W., Osadnik, C., Phu, S., et al. (2020). Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: A systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 11(5), 1164–1176.

Supriya, R., Singh, K. P., Gao, Y., et al. (2021). A multifactorial approach for sarcopenia assessment: A literature review. Biology, 10(12), 1354.

Tsekoura, M., Tsepis, E., Billis, E., et al. (2020). Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population. Lung India, 37(6), 479–484.

Trajanoska, K., Schoufour, J. D., Darweesh, S. K., et al. (2018). Sarcopenia and its clinical correlates in the general population: The Rotterdam study. Journal of Bone and Mineral Research, 33(7), 1209–1218.

Vaes, A. W., Sillen, M. J. H., Goërtz, Y. M. J., et al. (2021). The correlation between quadriceps muscle strength and endurance and exercise performance in patients with COPD. Journal of Applied Physiology.

van Bakel, S. I., Gosker, H. R., Langen, R. C. J., et al. (2021). Towards personalized management of sarcopenia in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 25–40.

Varmaghani, M., Dehghani, M., Heidari, E., et al. (2019). Global prevalence of chronic obstructive pulmonary disease: Systematic review and meta-analysis. Eastern Mediterranean Health Journal, 25(1), 47–57.

Wang, Y., Xu, J., Meng, Y., et al. (2018). Role of inflammatory cells in airway remodeling in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 3341–3348.

Wu, J.-F., Jia, J., Chen, P., et al. (2023). Sarcopenia and its clinical correlation in elderly chronic obstructive pulmonary disease: A prospective cohort study. European Review for Medical and Pharmacological Sciences, 27(20).

Zhao, X., Su, R., Hu, R., et al. (2023). Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: A cross-sectional study. BMC Geriatrics, 23(1), 89.

Zhao, Y., He, Q., & Xu, Z. (2024). Impact of sarcopenia on the quality of life and mobility in elderly patients with chronic obstructive pulmonary disease. Physical & Occupational Therapy in Geriatrics, 1–11.

Downloads

Published

2026-09-08